Instituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Argentina.
Instituto de Inmunología Clínica y Experimental Rosario (IDICER), CONICET-UNR, Rosario, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de Rosario, Rosario, Argentina.
Life Sci. 2022 Jul 15;301:120614. doi: 10.1016/j.lfs.2022.120614. Epub 2022 May 6.
Previous studies in TB patients showed an immuno-endocrine imbalance characterized by a disease-severity associated increase in plasma levels of proinflammatory cytokines and glucocorticoids (GCs). To analyze the potential immunomodulatory effect of circulating GCs over peripheral blood mononuclear cells (PBMC) from TB patients, we investigated the expression of positively (anti-inflammatory-related genes ANXA1; FKBP51; GILZ, NFKBIA, and NFKBIB) and negatively (inflammatory genes: IL-6, IL-1β, and IFN-γ) Glucocorticoids Receptors (GR)-regulated genes. Plasma concentrations of cytokines and hormones, together with specific lymphoproliferation were also assessed.
Gene expression was quantified by RT-qPCR, specific lymphoproliferation by H-thymidine incorporation, whereas plasma cytokines and hormones levels by ELISA.
Transcripts of ANXA1, GILZ, NFKBIB, and NFKBIA appeared significantly increased in patients, whereas FKBP51, IL-6, IL-1β, and NF-κB remained unchanged. Upon analyzing according to disease severity, mRNA levels for ANXA1 and NFKBIB were even higher in moderate and severe patients. GILZ was increased in moderate cases, with NFKBIA and IL-1 β being higher in severe ones, who also displayed increased GRβ transcripts. TB patients had reduced plasma DHEA concentrations together with increased pro and anti-inflammatory cytokines (IFN-γ, IL-6, and IL-10) cortisol and cortisol/DHEA ratio, more evident in progressive cases, in whom their PBMC also showed a decreased mycobacterial-driven proliferation. The cortisol/DHEA ratio and GRα expression were positively correlated with GR-regulated genes mainly in moderate patients.
The increased expression of cortisol-regulated anti-inflammatory genes in TB patients-PBMC, predominantly in progressive disease, seems compatible with a relatively insufficient attempt to downregulate the accompanying inflammation.
先前针对结核病患者的研究表明,存在免疫内分泌失衡的情况,其特征为促炎细胞因子和糖皮质激素(GCs)的血浆水平与疾病严重程度相关增加。为分析循环 GCs 对结核病患者外周血单个核细胞(PBMC)的潜在免疫调节作用,我们研究了阳性(与抗炎相关的基因 ANXA1;FKBP51;GILZ、NFKBIA 和 NFKBIB)和阴性(炎症基因:IL-6、IL-1β 和 IFN-γ)糖皮质激素受体(GR)调节基因的表达。还评估了细胞因子和激素的血浆浓度以及特异性淋巴细胞增殖。
通过 RT-qPCR 定量基因表达,通过 H-胸腺嘧啶掺入评估特异性淋巴细胞增殖,通过 ELISA 评估血浆细胞因子和激素水平。
在患者中,ANXA1、GILZ、NFKBIB 和 NFKBIA 的转录本明显增加,而 FKBP51、IL-6、IL-1β 和 NF-κB 则保持不变。根据疾病严重程度进行分析时,中度和重度患者的 ANXA1 和 NFKBIB mRNA 水平甚至更高。GILZ 在中度病例中增加,NFKBIA 和 IL-1β 在重度病例中增加,后者还显示 GRβ 转录本增加。结核病患者的血浆 DHEA 浓度降低,同时促炎和抗炎细胞因子(IFN-γ、IL-6 和 IL-10)、皮质醇和皮质醇/DHEA 比值增加,在进展性病例中更为明显,这些患者的 PBMC 也显示出结核分枝杆菌驱动的增殖减少。皮质醇/DHEA 比值和 GRα 表达与 GR 调节基因呈正相关,主要在中度患者中。
在结核病患者-PBMC 中,皮质醇调节的抗炎基因表达增加,主要在进行性疾病中,这似乎与下调伴随炎症的相对不足的尝试相一致。